These medtech companies raised the most VC last year

Perhaps there’s a ray of hope that venture capital funding is recovering a bit for the medical device industry. VC firms invested more than $2.8 billion in 2017, an increase of more than $647 million from 2016, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and CB Insights. There were a total 229 deals involving

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Medtech stories we missed this week: Jan. 19, 2018

From Privi Medical’s FDA clearance to OrthoXel getting FDA clearance and CE Mark approval, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Privi Medical wins FDA nod for hemorrhoid device Privi Medical has received FDA clearance for its Instalief Hemorrhoids Treatment device, according to a Jan. 18 news

How medtech could stop the drug overdose crisis in the U.S.

The opioid epidemic is one of the deadliest problems facing the U.S. today. Through the development of new pain management devices, medtech could be a leader in solving the crisis. The prescription opioid overdose crisis in America didn’t start until the late 1990s, when pharmaceutical companies touted prescription painkillers that weren’t supposed to be addictive.

This startup is bringing vision care to developing countries

PlenOptika, an MIT startup, has developed a portable autorefractor device that measures refractive errors of the eye and is able to estimate prescriptions in 10 seconds, bringing vision care to less accessible areas. The device, known as QuickSee, is more cost-effective than current technology and is currently on the market in India. “People at the

Victrex opens $13 million Polymer Innovation Center

Victrex recently announced that it has opened its new $13 million Polymer Innovation Center in Thornton Cleveleys, U.K. to help accelerate innovation. Victrex currently makes high-performance polyaryletherketone (PAEK) as well as selected parts for gears and dental discs. In hopes of developing next-generation thermoplastic solutions, the new facility is fully-operational and is dedicated to research

Medtech stories we missed this week: Dec. 29, 2017

From NanoVibronix’s new Indian regulatory and distribution agreement to Guided Therapeutics’s Turkish distribution deal, here are five medtech stories we missed this week but thought were still worth mentioning. 1. NanoVibronix inks deal with Indian regulatory and distribution consultant NanoVibronix announced in a Dec. 20 press release that it has signed Morulaa HealthTech as its regulatory

Medtech stories we missed this week: Dec. 22, 2017

From Hepa Wash’s new collaboration to Stimwave’s FDA clearance, here are five medtech stories we missed this week but thought were still worth mentioning. 1. Hepa Wash collaborates with GALS program Hepa Wash announced in a Dec. 7 press release that it has collaborated with the German Accelerator Life Sciences (GALS) program to expand its

That time Roald Dahl invented a medical device

Roald Dahl is best remembered as an author of children’s books, particularly for works like Charlie and the Chocolate Factory and Matilda. His stories have sold more than 250 million copies around the globe. But Dahl was much more than a storyteller: He also helped invent a medical device that has been used on nearly 3,000 children worldwide, according

How modern medicine changed ancient antidotes

Modern medicine is revolutionary in comparison to how different diseases and disorders were treated in ancient times. Without regulation, its no surprise that methods like drilling a hole in the skull to relieve a headache and using enemas to treat asthma were normal practice. With the FDA’s founding in 1906, many devices and practices have

7 medical devices combating the opioid crisis

Opioid-related deaths have become an epidemic in the U.S., garnering attention from the White House, the FDA and many other governmental bodies. From 2000 to 2014, nearly half a million Americans died from drug overdoses. In 2015, more than 50,000 people died from drug overdoses, and 33,000 were opioid-related. Prescription overdoses continue to cause more

Pages: 1 2 3 4 5 6 7 8

Millar offloads telemetry product line to Kaha Sciences

Medical device and OEM company Millar said today it is selling its lifesciences telemetry product division to New Zealand-based Kaha Sciences. Houston-based Millar said the divestiture comes as the company looks to focus its efforts on the clinical and OEM business segments in a strategy that emerged earlier this year. Kaha Sciences has picked up a handful

InstruSafe and Senhance Surgical Robotic System partner to launch instrument trays

Summit Medical’s InstruSafe and TransEnterix’s Senhance Surgical Robotic System  have forged a partnership to launch two new surgical instrument trays for use with the robotic platform. The two new trays will include an instrument tray an an endoscopic adapter tray, both of which have been validated for the Senhance instrumentation. “We are excited to expand our product offering

Omnia Medical receives FDA 510(k) clearance for vertebral body replacement system

Omnia Medical has received FDA 510(k) clearance for a vertebral body replacement (VBR) system for use in the thoracolumbar spine to replace collapsed, damaged or unstable vertebral body. The VBR system is manufactured from PEEK-Optima HA enhanced polymer through a collaboration with Jalex Medical on product development and regulatory activities and Invibio Biomaterial Solutions who

Medtech stories we missed this week: Dec. 8, 2017

From Minimus Spine’s European distribution deal to Stimwave receiving FDA clearance, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Minimus Spine inks EU distribution deal Minimus Spine announced in a Dec. 4 press releasethat it has signed its first European distribution deal with Italian company Moss and

Sterifre Medical raises nearly $5 million for desktop sterilization device

Sterifre Medical, a company that has developed a desktop sterilization device that only uses room temperature plasma, has raised nearly $5 million in its present funding round, according to a recent U.S. Securities and Exchange Commission filing. The company has raised $4,827,500 toward its present $12 million goal, according to a Form D filed with